![Jonathan Finn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Finn
Directeur/Membre du Conseil chez
ATOSSA THERAPEUTICS, INC.
Fortune : 61 013 $ au 31/05/2026
Profil
Jonathan Frederick Finn is currently Independent Director at Atossa Therapeutics, Inc. since 2023.
Mr. Finn is also Director at Solör Bioenergi Holding AB, Verigraft AB, and eReceivables Inc. Mr. Finn serves as Executive Vice President & CIO at Vantage Consulting Group, Inc. since 1995.
Mr. Finn is General Partner at Scientia Ventures LLC since 2006.
Former positions include Director at Rose Pharma A and Director at Solør Bioenergi Holding AS.
Education includes undergraduate studies at the University of Virginia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/05/2026 | 11 666 ( 0,14 % ) | 61 013 $ | 31/05/2026 |
Postes actifs de Jonathan Finn
| Sociétés | Poste | Début |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/11/2023 |
Solör Bioenergi Holding AB
 Solör Bioenergi Holding AB Electric UtilitiesUtilities Produces and distributes district heating, steam & electricity | Private Equity Investor | - |
Vantage Consulting Group, Inc.
 Vantage Consulting Group, Inc. Investment ManagersFinance Vantage strives to deliver a comprehensive, bespoke investment solution firmly grounded in fundamental investment principles. At the core of this solution lies an investment strategy meticulously tailored to their clients’ unique investment objectives, risk tolerances, diversification preferences, and their specific liquidity needs and investment horizons. | Directeur en chef des Investissements | 01/06/1995 |
Scientia Ventures LLC
 Scientia Ventures LLC Investment ManagersFinance Scientia Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. It participates in early stage transactions. | Directeur en chef des Investissements | 01/01/2006 |
ERECEIVABLES INC.
 ERECEIVABLES INC. Information Technology ServicesTechnology Services Provides information technology services that simplified the handling of insurance claims appeals | Private Equity Investor | - |
Verigraft
 Verigraft BiotechnologyHealth Technology Engages in development of personalized human tissues for transplantation | Directeur/Membre du Conseil | - |
Anciens postes connus de Jonathan Finn
| Sociétés | Poste | Fin |
|---|---|---|
Rose Pharma A/S
 Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome | Private Equity Investor | - |
Solør Bioenergi Holding AS
 Solør Bioenergi Holding AS Electric UtilitiesUtilities Produces, distributes and sells wood-based bioenergy | Private Equity Investor | - |
Formation de Jonathan Finn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rose Pharma A/S
Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome | Health Technology |
Vantage Consulting Group, Inc.
Vantage Consulting Group, Inc. Investment ManagersFinance Vantage strives to deliver a comprehensive, bespoke investment solution firmly grounded in fundamental investment principles. At the core of this solution lies an investment strategy meticulously tailored to their clients’ unique investment objectives, risk tolerances, diversification preferences, and their specific liquidity needs and investment horizons. | Finance |
Solør Bioenergi Holding AS
Solør Bioenergi Holding AS Electric UtilitiesUtilities Produces, distributes and sells wood-based bioenergy | Utilities |
Solör Bioenergi Holding AB
Solör Bioenergi Holding AB Electric UtilitiesUtilities Produces and distributes district heating, steam & electricity | Utilities |
Scientia Ventures LLC
Scientia Ventures LLC Investment ManagersFinance Scientia Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. It participates in early stage transactions. | Finance |
Verigraft
Verigraft BiotechnologyHealth Technology Engages in development of personalized human tissues for transplantation | Health Technology |
ERECEIVABLES INC.
ERECEIVABLES INC. Information Technology ServicesTechnology Services Provides information technology services that simplified the handling of insurance claims appeals | Technology Services |
